We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Drug facilitated sexual assault (DFSA), including rapes in which drugs are mixed with alcohol, is a significant problem, the Advisory Council…
In March 2009, the then Home Secretary requested advice from the Advisory Council on the Misuse of Drugs (ACMD) on so called ‘legal highs’. …
A review of the evidence of use and harm of Methiopropamine (MPA) by the Advisory Council on the Misuse of Drugs (ACMD).
In July 2007 the Home Secretary requested, in the light of “real public concern about the potential mental health effects of cannabis use, in…
The Advisory Council on the Misuse of Drugs (ACMD) has today (12 March) published a major report on powdered cocaine and its impact on British society.
In October 2010 the minister responsible for drugs asked the ACMD to review khat by considering the available evidence and to advise the government…
Advice from the Advisory Council on the Misuse of Drugs (ACMD) to the Home Office about the scheduling of cannabis-derived medicinal products.
An assessment of the impact of rescheduling CBPMs to Schedule 2 under the Misuse of Drugs Regulations 2001 (MDR) and recommendations to mitigate the issues identified.
ACMD chair Les Iversen writes to Sarah Newton, Minister for Vulnerability, Safeguarding and Countering Extremism, about phytocannabinoids.
The Advisory Council on the Misuse of Drugs (ACMD) has today (6 March 2023) published an updated harms assessment of nitrous oxide.
Advice on preventing drug misuse among vulnerable groups of people, with a focus on understanding factors that contribute to vulnerability.
The ACMD Recovery Committee’s first report on factors contributing to recovery from drug or alcohol dependence.
Recommendations from the ACMD to reduce barriers to research for schedule 1 controlled drugs.
The Advisory Council on the Misuse of Drugs response to the consultation by NICE on the draft scope of their guidance on cannabis-based products for medicinal use.
Minister for Vulnerability, Safeguarding and Countering Extremism Sarah Newton today (14 December) announced Dr Owen Bowden-Jones as the new chair of the ACMD.
Advisory Council on the Misuse of Drugs (ACMD) call for evidence on cannabinoids in CBD products.
Letter about the prescribing of controlled drugs by therapeutic radiographers.
A letter to the Advisory Council on the Misuse of Drugs about U-47,700 and designer benzodiazepines.
The government responds to a report by the Advisory Council on the Misuse of Drugs and commissions Part 2 of work on barriers to research.
Letter to Victoria Atkins MP from the chair of the Advisory Council on the Misuse of Drugs outlining recommendations for amending the safe custody regulations.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey.